Puerto Rico gives its medical cannabis programme a statutory base

Puerto Rico gave its operating medical-cannabis programme a statutory base on 9 July 2017. Patients following the law and its regulations gained protection from Puerto Rico criminal and municipal sanctions, while access depended on an authorised doctor’s recommendation, identification and regulated dispensary supply.

Dispensaries had opened under the earlier administrative system

Governor Alejandro García Padilla’s 2015 executive order had directed the health secretary to use existing legal powers to authorise medical cannabis. Reclassification, regulations and licensing followed.

The first two dispensaries opened in December 2016. At that point, the outgoing administration reported almost two thousand registered patients.

The new law’s findings criticised the earlier approach for lacking sufficient legislative guidance. Lawmakers sought clearer rules for patients, communities and businesses, with research and medical expertise informing the programme.

A board took responsibility for the medical market

The law established a Medical Cannabis Regulatory Board within the health department. Its responsibilities covered cultivation, manufacturing, laboratories, transportation, dispensaries and the people working in those activities.

Cannabis was placed in the second controlled-substance classification. Protection from local criminal sanctions depended on acting within the medical law and its regulations.

Existing businesses received a transition into the new system. The law provided time to adjust licences and applications after new regulations, with provisional certification for businesses still completing compliance requirements.

Patients needed identification and a medical relationship

Doctors recommending cannabis had to maintain a real clinical relationship with the patient and explain its risks and benefits. Resident patients needed board-issued photographic identification; the law also recognised identification from the relevant jurisdiction for nonresident patients.

Use was confined to homes and private places. Smoking was prohibited, and patients could not consume cannabis in dispensaries.

The statute allowed vaporisation and provided an exceptional route for authorising vaporised flower for terminal illness or when other treatments were unsuitable. Medical advice and board rules therefore shaped the forms of cannabis a patient could use.

Patient rights continued to develop

The law kept transfers within authorised dispensary channels and prohibited patients from selling or distributing surplus cannabis. Packaging and advertising also faced restrictions intended to protect young people.

Later, the 2021 employment amendment added protection against discrimination for registered patients who identified themselves to employers. A 2022 disability-law change addressed another barrier to protection.

Together, those later changes extended the medical programme in Puerto Rico beyond rules for obtaining and possessing cannabis into patients’ working lives and civil rights.^[1][2][3]